Project Details
Description
A Phase II Study of Patients with Recurrent Glioblastoma Treated with Maximal Safe Neurosurgical Resection, Intra-Operative Radiation Therapy (IORT) Using the Xoft?? Axxent?? Electronic Brachytherapy System (GLIOX) and post-radiation adjuvant Bevacizumab
| Status | Active |
|---|---|
| Effective start/end date | 7/21/22 → 8/1/27 |
Funding
- ICAD, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.